U.S. market Closed. Opens in 18 hours 49 minutes

BCTXW | BriaCell Therapeutics Corp. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2024-07-312023-07-312022-07-312021-07-312020-07-312019-07-312018-07-312017-07-312016-07-312015-07-312014-07-312013-07-312012-07-312011-07-312010-07-312009-07-312008-07-312007-07-312006-07-31
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cost of RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Gross ProfitN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Expenses33.33M23.27M-3.39K-3.69M-1.38M-946.42K-1.07MN/A1.67M1.44M437.27K424.26K551.84K1.05M324.57K233.87K114.12K129.06K8.58K
Selling, General & Admin6.15M7.94M7.27M-3.67M-1.37M-932.17K-1.05MN/A942.02K1.33M436.17K423.86K556.06K1.05M323.27K203.86K114.12K129.06K8.58K
Research & Development27.18M15.34M8.02M1.32M2.22M3.74M2.39MN/A723.43K105.82KN/AN/AN/AN/AN/AN/AN/AN/AN/A
Other Operating ExpensesN/AN/AN/AN/A-58.98K319.86K-312.92KN/AN/AN/AN/AN/AN/AN/AN/A2.33KN/AN/AN/A
Operating Income-4.79M-23.27M-15.29M-6.97M-3.61M-4.73M-3.82MN/A-1.67M-1.44M-437.27K-424.26K-1.20M-1.05M-324.57K-233.87K-114.12K-129.06K-8.58K
Other Expenses / IncomeN/A2.97M3.74M-6.84M-85.10K5.68M4.88MN/A-28.77K-1.24M-7.71M55.56K202.71K-38.96K-579.07K2.33KN/AN/AN/A
Before Tax Income-4.79M-20.30M-11.55M3.69M1.38M946.42K1.07MN/A-1.70M-2.68M-8.15M-368.69K-995.72K-1.09M-903.64K-231.54KN/AN/AN/A
Income Tax ExpensesN/A-152.62K979.006.58M-72.25K343.74K-331.40KN/A29.24K1.24M7.71M-55.56K443.88K25.60K576.17K-2.73K98.93K116.41K8.58K
Net Income-4.79M-20.30M-11.55M3.69M1.38M946.42K1.07MN/A-1.70M-2.68M-8.15M-368.69K-995.72K-1.08M-900.74K-228.81K-98.93K-116.41K-8.58K
Interest ExpensesN/AN/A979.0046.09K27.00K23.82K15.63KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding16.45M15.52MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Diluted Shares Outstanding16.45M15.52MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBITDA-4.79M-22.37M-11.50M3.71M1.40M960.68K1.08MN/A-1.63M-191.61K7.28M-462.53K-68.23K-1.01M255.79K-233.72K-114.12K-129.06K-8.58K
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-4.79M-20.46M-11.55M10.32M1.34M1.31M749.30KN/A-1.67M-1.44M-437.27K-424.26K-551.84K-1.05M-324.57K-231.54K00N/A
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2024-07-312023-07-312022-07-312021-07-312020-07-312019-07-312018-07-312017-07-312016-07-312015-07-312014-07-312013-07-312012-07-312011-07-312010-07-312009-07-312008-07-312007-07-312006-07-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙